Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06612346

Enrollment

Registered

2024-09-25

Start date

2022-11-04

Completion date

2024-12-31

Last updated

2025-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open Angle Glaucoma

Keywords

MINT, Trabeculostomy, Minimally Invasive Glaucoma Surgery, MIGS, Intraocular Pressure

Brief summary

This study is a follow-up extension study conducted in continuation of the prior MINT study (MMS-EEU-4), in which the long-term (i.e., 18, 24 months) clinical outcomes of Minimally Invasive Nasal Trabeculostomy (MINT) will be explored.

Interventions

DEVICEMinimally Invasive Micro Trabeculostomy

The MINT system is a surgical device designed to create a trabeculostomy within the eye.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

1. Male or female ≥ 18 years to ≤ 85 years old 2. Subject who underwent MINT, and surgery was performed not earlier than 18 months from enrollment

Design outcomes

Primary

Measure	Time frame	Description
Intraocular Pressure Measurement	18 months +/- 2 months post-MINT surgery from previous study (MMS-EEU-4).	Observed IOP at long-term timepoints

Other

Measure	Time frame	Description
Adverse Events Outcomes	0-24 +/-2 months post MINT surgery from previous study (MMS-EEU-4).	Incidence of adverse events related to MINT device/procedure, including visual acuity and postoperative complications, throughout the study follow-up.

Countries

Armenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026